THE JOINT ACTION ON PATIENT, PHYSICIAN AND PHARMACIST IN ORDER TO IMPROVE ADHERENCE TO MEDICATION (CROSBI ID 646773)
Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija
Podaci o odgovornosti
Prga, Ivana ; Bago, Martina ; Leppee, Marcel ; Culig, Josip ; Radman, Ivana
engleski
THE JOINT ACTION ON PATIENT, PHYSICIAN AND PHARMACIST IN ORDER TO IMPROVE ADHERENCE TO MEDICATION
Background: Medication adherence usually refers to whether patients take their medications as prescribed and whether they continue to take a prescribed medication. The impact of poor adherence grows as the burden of chronic disease grows worldwide. Adherence to long-term therapy for chronic illnesses in developed countries averages 50%. Objectives: Objective is improve adherence to medication, especially among patients with multimorbidity. Methods: Design: The cross-sectional survey was conducted at 106 Zagreb, Croatia pharmacies and the questionnaire was filled out by the study subjects ; we used a 33-item self-administered questionnaire. Setting: A convenience sample of 635 individuals who were buying drugs for the treatment of chronic diseases. Main outcome measures: Study subjects were divided into two groups, with adherent defined as a “yes” response to the statement that they “never fail to take their medication on time.” Statistical analysis: Student’s t-test and Chi-square test with a significance level of p<=0.05 were used when appropriate for the evaluation of the results. Results: In our study population (n=635), non-adherent subjects prevailed over adherent subjects (n=370 ; 58.3% vs. n=265 ; 41.7%). The most common diagnoses were diseases of the circulatory system (n=500 ; 36.8%) and endocrine, nutritional and metabolic diseases (n=285 ; 21.0%). The great majority of study subjects reported forgetfulness (“I just forgot”) as the main reason for skipping drug doses, followed by being away from home and shortage of the drug (having consumed it all). Conclusions: Nonadherence to medication is a growing concern to patients, physicians, healthcare systems, and other stakeholders because that it is prevalent and associated with adverse outcomes and higher costs of care. There is usually no single reason for medication nonadherence, and therefore must be a comprehensive approach to improve adherence. Research on adherence has typically focused on the barriers patients face in taking their medications. Common barriers to adherence are under the patient’s control, so that attention to them is a necessary and important step in improving adherence.
adherence ; patient ; improve ; multimorbidity
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
192-192.
2016.
objavljeno
Podaci o matičnoj publikaciji
1099-1557
Podaci o skupu
32nd International Conference on Pharacoepidemiology and Therapeutic Risk Management
poster
25.08.2016-28.08.2016
Dublin, Irska
Povezanost rada
Javno zdravstvo i zdravstvena zaštita, Farmacija